Noven Pharmaceuticals (NOVN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Noven Pharmaceuticals (NOVN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Todd D. Wiener who wrote (30)	11/10/1997 11:45:00 PM
From: John McCarthy	Read Replies (1) of 66

TODD biz.yahoo.com In short ... At the end of September, the company had 20,471,596 shares outstanding. In addition, the company expects to report break-even results for the third quarter ended 1997 on higher total revenues compared to a loss of ($.10) per share for the second quarter ended 1997. Noven will report its third quarter results on Nov. 12, 1997. Regards, John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next